SOUTH SAN FRANCISCO, Calif.,
Oct. 25, 2019 /PRNewswire/ -- IDEAYA
Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision
medicine company committed to the discovery and development of
targeted therapeutics for patient populations selected using
molecular diagnostics, announced that the company is scheduled to
present in the following investor conferences:
- Stifel 2019 Healthcare Conference in New York City, NY. The company is scheduled to
present on Wednesday, November 20th
at 3:35 pm ET (12:35 pm PST)
- Jefferies 2019 London Healthcare Conference in London, United Kingdom. The company is
scheduled to present on Thursday, November
21st at 7:20am GMT+1 (11:20 pm
PST)
About IDEAYA Biosciences
IDEAYA is an oncology-focused precision medicine company
committed to the discovery and development of targeted therapeutics
for patient populations selected using molecular diagnostics.
IDEAYA's approach integrates capabilities in identifying and
validating translational biomarkers with small molecule drug
discovery to select patient populations most likely to benefit from
the targeted therapies IDEAYA is developing. IDEAYA is
applying these capabilities across multiple classes of precision
medicine, including direct targeting of oncogenic pathways and
synthetic lethality – which represents an emerging class of
precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements,
including statements related to participation in and/or
presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's recent
Quarterly Report on Form 10-Q filed on August 12, 2019 and any current and periodic
reports filed with the U.S. Securities and Exchange Commission.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ideaya-biosciences-to-present-at-upcoming-investor-conferences-300945186.html
SOURCE IDEAYA Biosciences, Inc.